With experimental drugs, 'right to try' can go wrong
July 29, 2016 | Kirstin R.W. Matthews

Table of Contents
Author(s)
Kirstin R.W. Matthews
Fellow in Science and Technology PolicyBy Kirstin R.W. Matthews and Michelle Rubin
Access to experimental drugs by terminally ill patients is a highly contested topic. Authors discuss the benefits and consequences of "right to try" laws, which grant patient access to such drugs. TribTalk: http://bit.ly/2akfGKR